We see great value in advancing innovation from multiple sources and seek opportunities to partner with companies who share our aspiration to cure cancer. 

Our global footprint and broad capabilities allow us to enter a variety of unique partnerships, which have resulted in important advances for patients. 

Our partnership approach strengthens our work at every stage of development and helps us accelerate the delivery of our treatments to patients.